Search hospitals

>

California

>

Irvine

City of Hope at Irvine Lennar

Claim this profile

Irvine, California 92618

Global Leader in Lung Cancer

Global Leader in Breast Cancer

Conducts research for Non-Small Cell Lung Cancer

Conducts research for Cancer

Conducts research for Breast cancer

53 reported clinical trials

32 medical researchers

Photo of City of Hope at Irvine Lennar in IrvinePhoto of City of Hope at Irvine Lennar in IrvinePhoto of City of Hope at Irvine Lennar in Irvine

Summary

City of Hope at Irvine Lennar is a medical facility located in Irvine, California. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Cancer, Breast cancer and other specialties. City of Hope at Irvine Lennar is involved with conducting 53 clinical trials across 126 conditions. There are 32 research doctors associated with this hospital, such as Daneng Li, MD, Mark Agulnik, Vincent Chung, MD, and Marwan Fakih, MD.

Area of expertise

1

Lung Cancer

Global Leader

City of Hope at Irvine Lennar has run 26 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
EGFR positive
2

Breast Cancer

Global Leader

City of Hope at Irvine Lennar has run 19 trials for Breast Cancer. Some of their research focus areas include:

ER positive
Stage IV
HER2 negative

Top PIs

Clinical Trials running at City of Hope at Irvine Lennar

Lung Cancer

Breast Cancer

Skin Cancer

Breast cancer

Cancer

Colorectal Cancer

Non-Small Cell Lung Cancer

Follicular Lymphoma

Ovarian Cancer

Multiple Myeloma

Image of trial facility.

Telisotuzumab Vedotin vs. Docetaxel

for Non-Small Cell Lung Cancer

This trial is testing a new drug called telisotuzumab vedotin to see if it can treat a specific type of lung cancer better than an existing drug. The study focuses on adults whose lung cancer has not responded to previous treatments. The new drug targets and kills cancer cells by attaching to a specific protein on their surface.

Recruiting

2 awards

Phase 3

12 criteria

Image of trial facility.

Radiotherapy

for Lung Cancer

This study is being done to answer the following question: Can the chance of lung cancer growing or spreading be lowered by adding targeted radiotherapy to the usual combination of drugs? This study is being done to find out if this approach is better or worse than the usual approach for lung cancer. The usual approach is defined as the care most people get for non-small cell lung cancer.

Recruiting

2 awards

Phase 3

4 criteria

Image of trial facility.

Radiation Therapy

for Brain Metastasis

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.

Recruiting

2 awards

Phase 3

12 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at City of Hope at Irvine Lennar?